Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?
This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We an...
Gespeichert in:
| Veröffentlicht in: | Annals of hematology 2015-07, Vol.94 (7), p.1195-1203 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1203 |
|---|---|
| container_issue | 7 |
| container_start_page | 1195 |
| container_title | Annals of hematology |
| container_volume | 94 |
| creator | Stienen, J. J. C. Ottevanger, P. B. Wennekes, L. van de Schans, S. A. M. Dekker, H. M. van der Maazen, R. W. M. van Krieken, J. H. J. M. Blijlevens, N. M. A. Hermens, R. P. M. G. |
| description | This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We analyzed data collected from medical records in two observational studies, combined into 20 validated quality indicators (QIs) of which 6 were included in the national program. A random sample of 771 patients, diagnosed with NHL in 26 Dutch hospitals, was examined. Multilevel regression analyses were used to assess differences in quality of NHL care and to provide insight into the effect of the national program. We reported improved adherence to only 3 out of 6 QIs involved in the national program and none of the other 14 validated QIs. Improvement was shown for performance of all recommended staging techniques (from 26 to 43 %), assessment of International Prognostic Index (from 21 to 43 %), and multidisciplinary discussion of patients (from 23 to 41 %). We found limited improvement in quality of NHL care between 2007 and 2011; improvement potential ( |
| doi_str_mv | 10.1007/s00277-015-2340-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4432098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1681266928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-f47149ebba63435dc0346af95181b8b6dfa7dffa19489ab75128b132b3849a693</originalsourceid><addsrcrecordid>eNp1kctu1TAQhi0EoofCA7BBltiwMYwvsWMWIFTRi1SJTVlbduKkLol9aidIZ8dr8Ho8CT46pSpIzGYW880_lx-hlxTeUgD1rgAwpQjQhjAugMAjtKGCMwJNKx6jDWiuSVPjCD0r5QaAslawp-iINUoxyWGDLq6yj33BIeLb1U5h2eE04JgiOU_9-C3EXz9-Fjzt5u11mi3ubPbvcaj8gke_LCGO2NXs88fn6Mlgp-Jf3OVj9PX089XJObn8cnZx8umSdELBQgahqNDeOSu54E3fARfSDrqhLXWtk_1gVT8MlmrRautUU3d2lDPHW6Gt1PwYfTjoblc3-77zccl2MtscZpt3Jtlg_q7EcG3G9N2I-hnQbRV4cyeQ0-3qy2LmUDo_TTb6tBZDZUuZlJrt0df_oDdpzbGet6dAU6kYrxQ9UF1OpWQ_3C9DweyNMgejTDXK7I0yUHtePbzivuOPMxVgB6DUUhx9fjD6v6q_AeAOnlc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680916723</pqid></control><display><type>article</type><title>Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Stienen, J. J. C. ; Ottevanger, P. B. ; Wennekes, L. ; van de Schans, S. A. M. ; Dekker, H. M. ; van der Maazen, R. W. M. ; van Krieken, J. H. J. M. ; Blijlevens, N. M. A. ; Hermens, R. P. M. G.</creator><creatorcontrib>Stienen, J. J. C. ; Ottevanger, P. B. ; Wennekes, L. ; van de Schans, S. A. M. ; Dekker, H. M. ; van der Maazen, R. W. M. ; van Krieken, J. H. J. M. ; Blijlevens, N. M. A. ; Hermens, R. P. M. G. ; PEARL study group ; On behalf of the PEARL study group</creatorcontrib><description>This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We analyzed data collected from medical records in two observational studies, combined into 20 validated quality indicators (QIs) of which 6 were included in the national program. A random sample of 771 patients, diagnosed with NHL in 26 Dutch hospitals, was examined. Multilevel regression analyses were used to assess differences in quality of NHL care and to provide insight into the effect of the national program. We reported improved adherence to only 3 out of 6 QIs involved in the national program and none of the other 14 validated QIs. Improvement was shown for performance of all recommended staging techniques (from 26 to 43 %), assessment of International Prognostic Index (from 21 to 43 %), and multidisciplinary discussion of patients (from 23 to 41 %). We found limited improvement in quality of NHL care between 2007 and 2011; improvement potential (<80 % adherence) was still present for 13 QIs. The national program seems to have a small positive effect, but has not influenced all 20 indicators which represent the most important, measurable parts in quality of NHL care. These results illustrate the need for tailored implementation and quality improvement initiatives.</description><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-015-2340-0</identifier><identifier>PMID: 25772630</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Female ; Hematology ; Humans ; Longitudinal Studies ; Lymphoma, Non-Hodgkin - diagnosis ; Lymphoma, Non-Hodgkin - epidemiology ; Lymphoma, Non-Hodgkin - therapy ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Netherlands - epidemiology ; Oncology ; Original ; Original Article ; Quality of Health Care - trends</subject><ispartof>Annals of hematology, 2015-07, Vol.94 (7), p.1195-1203</ispartof><rights>The Author(s) 2015</rights><rights>Springer-Verlag Berlin Heidelberg 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-f47149ebba63435dc0346af95181b8b6dfa7dffa19489ab75128b132b3849a693</citedby><cites>FETCH-LOGICAL-c470t-f47149ebba63435dc0346af95181b8b6dfa7dffa19489ab75128b132b3849a693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00277-015-2340-0$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00277-015-2340-0$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25772630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stienen, J. J. C.</creatorcontrib><creatorcontrib>Ottevanger, P. B.</creatorcontrib><creatorcontrib>Wennekes, L.</creatorcontrib><creatorcontrib>van de Schans, S. A. M.</creatorcontrib><creatorcontrib>Dekker, H. M.</creatorcontrib><creatorcontrib>van der Maazen, R. W. M.</creatorcontrib><creatorcontrib>van Krieken, J. H. J. M.</creatorcontrib><creatorcontrib>Blijlevens, N. M. A.</creatorcontrib><creatorcontrib>Hermens, R. P. M. G.</creatorcontrib><creatorcontrib>PEARL study group</creatorcontrib><creatorcontrib>On behalf of the PEARL study group</creatorcontrib><title>Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><addtitle>Ann Hematol</addtitle><description>This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We analyzed data collected from medical records in two observational studies, combined into 20 validated quality indicators (QIs) of which 6 were included in the national program. A random sample of 771 patients, diagnosed with NHL in 26 Dutch hospitals, was examined. Multilevel regression analyses were used to assess differences in quality of NHL care and to provide insight into the effect of the national program. We reported improved adherence to only 3 out of 6 QIs involved in the national program and none of the other 14 validated QIs. Improvement was shown for performance of all recommended staging techniques (from 26 to 43 %), assessment of International Prognostic Index (from 21 to 43 %), and multidisciplinary discussion of patients (from 23 to 41 %). We found limited improvement in quality of NHL care between 2007 and 2011; improvement potential (<80 % adherence) was still present for 13 QIs. The national program seems to have a small positive effect, but has not influenced all 20 indicators which represent the most important, measurable parts in quality of NHL care. These results illustrate the need for tailored implementation and quality improvement initiatives.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Lymphoma, Non-Hodgkin - diagnosis</subject><subject>Lymphoma, Non-Hodgkin - epidemiology</subject><subject>Lymphoma, Non-Hodgkin - therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Netherlands - epidemiology</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Quality of Health Care - trends</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kctu1TAQhi0EoofCA7BBltiwMYwvsWMWIFTRi1SJTVlbduKkLol9aidIZ8dr8Ho8CT46pSpIzGYW880_lx-hlxTeUgD1rgAwpQjQhjAugMAjtKGCMwJNKx6jDWiuSVPjCD0r5QaAslawp-iINUoxyWGDLq6yj33BIeLb1U5h2eE04JgiOU_9-C3EXz9-Fjzt5u11mi3ubPbvcaj8gke_LCGO2NXs88fn6Mlgp-Jf3OVj9PX089XJObn8cnZx8umSdELBQgahqNDeOSu54E3fARfSDrqhLXWtk_1gVT8MlmrRautUU3d2lDPHW6Gt1PwYfTjoblc3-77zccl2MtscZpt3Jtlg_q7EcG3G9N2I-hnQbRV4cyeQ0-3qy2LmUDo_TTb6tBZDZUuZlJrt0df_oDdpzbGet6dAU6kYrxQ9UF1OpWQ_3C9DweyNMgejTDXK7I0yUHtePbzivuOPMxVgB6DUUhx9fjD6v6q_AeAOnlc</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Stienen, J. J. C.</creator><creator>Ottevanger, P. B.</creator><creator>Wennekes, L.</creator><creator>van de Schans, S. A. M.</creator><creator>Dekker, H. M.</creator><creator>van der Maazen, R. W. M.</creator><creator>van Krieken, J. H. J. M.</creator><creator>Blijlevens, N. M. A.</creator><creator>Hermens, R. P. M. G.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150701</creationdate><title>Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?</title><author>Stienen, J. J. C. ; Ottevanger, P. B. ; Wennekes, L. ; van de Schans, S. A. M. ; Dekker, H. M. ; van der Maazen, R. W. M. ; van Krieken, J. H. J. M. ; Blijlevens, N. M. A. ; Hermens, R. P. M. G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-f47149ebba63435dc0346af95181b8b6dfa7dffa19489ab75128b132b3849a693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Lymphoma, Non-Hodgkin - diagnosis</topic><topic>Lymphoma, Non-Hodgkin - epidemiology</topic><topic>Lymphoma, Non-Hodgkin - therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Netherlands - epidemiology</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Quality of Health Care - trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stienen, J. J. C.</creatorcontrib><creatorcontrib>Ottevanger, P. B.</creatorcontrib><creatorcontrib>Wennekes, L.</creatorcontrib><creatorcontrib>van de Schans, S. A. M.</creatorcontrib><creatorcontrib>Dekker, H. M.</creatorcontrib><creatorcontrib>van der Maazen, R. W. M.</creatorcontrib><creatorcontrib>van Krieken, J. H. J. M.</creatorcontrib><creatorcontrib>Blijlevens, N. M. A.</creatorcontrib><creatorcontrib>Hermens, R. P. M. G.</creatorcontrib><creatorcontrib>PEARL study group</creatorcontrib><creatorcontrib>On behalf of the PEARL study group</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stienen, J. J. C.</au><au>Ottevanger, P. B.</au><au>Wennekes, L.</au><au>van de Schans, S. A. M.</au><au>Dekker, H. M.</au><au>van der Maazen, R. W. M.</au><au>van Krieken, J. H. J. M.</au><au>Blijlevens, N. M. A.</au><au>Hermens, R. P. M. G.</au><aucorp>PEARL study group</aucorp><aucorp>On behalf of the PEARL study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?</atitle><jtitle>Annals of hematology</jtitle><stitle>Ann Hematol</stitle><addtitle>Ann Hematol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>94</volume><issue>7</issue><spage>1195</spage><epage>1203</epage><pages>1195-1203</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><abstract>This study outlines trends in quality of delivered non-Hodgkin’s lymphoma (NHL) care in the Netherlands between 2007 and 2011 and to what extend this was influenced by the national Visible Care program, which aimed at increasing transparency by providing insight into the quality of healthcare. We analyzed data collected from medical records in two observational studies, combined into 20 validated quality indicators (QIs) of which 6 were included in the national program. A random sample of 771 patients, diagnosed with NHL in 26 Dutch hospitals, was examined. Multilevel regression analyses were used to assess differences in quality of NHL care and to provide insight into the effect of the national program. We reported improved adherence to only 3 out of 6 QIs involved in the national program and none of the other 14 validated QIs. Improvement was shown for performance of all recommended staging techniques (from 26 to 43 %), assessment of International Prognostic Index (from 21 to 43 %), and multidisciplinary discussion of patients (from 23 to 41 %). We found limited improvement in quality of NHL care between 2007 and 2011; improvement potential (<80 % adherence) was still present for 13 QIs. The national program seems to have a small positive effect, but has not influenced all 20 indicators which represent the most important, measurable parts in quality of NHL care. These results illustrate the need for tailored implementation and quality improvement initiatives.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>25772630</pmid><doi>10.1007/s00277-015-2340-0</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0939-5555 |
| ispartof | Annals of hematology, 2015-07, Vol.94 (7), p.1195-1203 |
| issn | 0939-5555 1432-0584 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4432098 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Aged Aged, 80 and over Female Hematology Humans Longitudinal Studies Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - epidemiology Lymphoma, Non-Hodgkin - therapy Male Medicine Medicine & Public Health Middle Aged Netherlands - epidemiology Oncology Original Original Article Quality of Health Care - trends |
| title | Trends in quality of non-Hodgkin’s lymphoma care: is it getting better? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A50%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20quality%20of%20non-Hodgkin%E2%80%99s%20lymphoma%20care:%20is%20it%20getting%20better?&rft.jtitle=Annals%20of%20hematology&rft.au=Stienen,%20J.%20J.%20C.&rft.aucorp=PEARL%20study%20group&rft.date=2015-07-01&rft.volume=94&rft.issue=7&rft.spage=1195&rft.epage=1203&rft.pages=1195-1203&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-015-2340-0&rft_dat=%3Cproquest_pubme%3E1681266928%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680916723&rft_id=info:pmid/25772630&rfr_iscdi=true |